1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
617A3A5BC9273CDCE002587300034D09A
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/db-leveraging-outcomes-data-training-kpis-staffing-health-economics-outcomes-research-cns-products?opendocument
18
19opendocument
203.237.16.210
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Medical Affairs Health Outcomes

Leveraging Outcomes Data – Training, KPIs, and Staffing in Health Economics & Outcomes Research for CNS Products

ID: 5692


Features:

7 Info Graphics

8 Data Graphics

65+ Metrics


Pages/Slides: 23


Published: 2021


Delivery Format: Online PDF Document


 

License Options:


Buy Now

 


  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • SPECIAL OFFER
Non-members: Click here to review a complimentary excerpt from “Leveraging Outcomes Data – Training, KPIs, and Staffing in Health Economics & Outcomes Research for CNS Products”

STUDY OVERVIEW

To gain market access and market share in the CNS marketplace, it is important for pharma companies to demonstrate the CNS product’s value proposition and its potential in real-world practice.

The Health Economics Outcomes Research function is an important player in generating value-oriented outcomes data, but success revolves around constant training, setting performance indicators, and maintaining effective staffing ratios.

Best Practices, LLC undertook this benchmarking research to identify how leading CNS manufacturers develop successful Health Outcomes groups. This study illustrates effective strategies for HEOR training, establishing KPIs, and staffing for CNS products.

Study insights are further segmented based on the HEOR reporting structure.

KEY TOPICS

  • KPIs to measure success of HEOR
  • HEOR training and development programs
  • HEOR staff size
  • Challenges and success factors in working with payers

KEY METRICS
  • Which types of training and development programs work best for HEOR groups?
  • How often are Health Outcomes groups trained?
  • What KPI(s) and metrics are the most effective in measuring the success of HEOR program?
  • What is the number of field staff that work in the HEOR organization? What is the number of field-based staff dedicated to HEOR structure?
  • Who heads the HEOR group?

SAMPLE KEY FINDINGS
  • Training & KPIs: Expanding HEOR roles to support drug development and research collection require training on a quarterly and semi-annually basis. Effective HEOR programs measure impact via KPIs. 43% of respondents optimistic about tracking RWD in the future.

METHODOLOGY

Best Practices, LLC engaged 16 executives from 14 pharmaceuticals offering CNS products. The study insights are mostly from directors and higher management executives, representing around ninety percent of the participants. Functional segments in the study will help pinpoint differences in value delivery among Medical Affairs and Commercial HEOR groups.

Industries Profiled:
Pharmaceutical; Manufacturing; Biotech; Consumer Products; Diagnostic; Medical Device; Health Care; Biopharmaceutical; Communications


Companies Profiled:
AbbVie; Alexion Pharmaceuticals; Bayer; Brii Biosciences; CSL Behring; Eisai; Greenwich Biosciences; Harmony Biosciences; Lundbeck; Merck; Novartis; Nucleus Global; Pfizer; Takeda Pharmaceuticals

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.